Date   

FP/Covid Task Team Meeting--Re-Group!

Nandita Thatte
 

Dear IBP FP Covid-9 Task Team Colleagues,
Hope you are well! Last year we decided to retire the IBP Covid-19 Task Team due to the abundance of Covid related content and the evolution of the pandemic. Since then, many partners have continued to embark on research and programmatic efforts to understand and respond to the challenges of family planning provision over the course of the pandemic.
As a result, it was suggested that prior to ICFP (where there will be large focus on Covid-19), it would be worth reconvening the FP/COVID Task Team to take stock of emerging evidence and insights, the knowledge gaps that remain, and how family planning programs continue to adapt as we enter a new phase of the pandemic. A follow-up meeting will be held after ICFP to share updates and insights gained during the conference.
Objectives of the October 26th meeting:

1. Hear brief updates from partners, including those who will be presenting at ICFP
2. Engage in discussion about what more is needed in knowledge and evidence to guide continued adaptations to FP programs
3. Identify any additional tools and/or resources needed to further support FP programs during future crises
We invite you to join us for this meeting. For those wishing to share an update (including any planned presentations at ICFP), please send 1 PPT slide with this information (in language of your choice) to Morrisa Malkin (mmalkin@...<mailto:mmalkin@...>) no later than October 19th. An example slide is attached. Simultaneous interpretation will not be available for the meeting, however French and Spanish speakers will be available to facilitate break out groups.
Meeting link: https://zoom.us/j/97032733268?pwd=N2RLdllwdVZYZW1vQVZTSlZOZlNjUT09
Meeting ID: 970 3273 3268
Passcode: 929279

Sincerely,

IBP Task Team Chairs
(IBP, FHI360, JHU-CCP)
[A picture containing chart Description automatically generated]


Reminder Tomorrow: Final WHO/IBP Covid-19 and FP/RH Task Team, 9hEST/15hCEST

Nandita Thatte
 

Dear All,

Just a reminder about our last Covid-19 and FP/RH Task Team tomorrow!

Please see link and agenda below.

________________________________

Dear IBP Covid-19 Task Team Members,

Hope all are well. Please see the link and agenda below for our last meeting on September 8th. Looking forward to it!

Join Zoom Meeting
https://us02web.zoom.us/j/81278836310?pwd=MVVabzkzSjhWODhybHVxWWVuVjIydz09

Meeting ID: 812 7883 6310
Passcode: 245557

[cid:image003.jpg@...]


Agenda:

* Key themes from the COVID-19 and FP/RH Story Map (FHI360)
* FP program adaptations during the COVID-19 pandemic (FHI360)
* Small group discussions on policy, SBC and service delivery adaptations (All)

________________________________

Dear IBP Covid-19 Task Team Members,

Hope all are well. We would like to organize one last Covid-19 Task Team Meeting in September. After much discussion and input from many of you, and given that Covid-19 continues to impact our daily work with many more resources available, it seems like a dedicated Task Team may no longer be required at this time. Our original "Tasks", of sharing updates on new guidance, program adaptations, and sharing Covid-19 response experiences has been met.

We can of course continue to share information and resources using the listserv (covid19@...<mailto:covid19@...>) and platform (https://ibpnetwork.org/topics/18248/feed) and if we feel the need to convene again in the future in a more formal way we can.

Looking forward to touching base in September and hope to keep the sharing going. Agenda and Zoom link to follow in the coming weeks.

With best wishes,

Nandita, Anne, Sarah, Trinity, on behalf of the Covid-19 Task Team


Save the Date: IBP Covid-19 and FP/RH Task Team

Nandita Thatte
 

Dear IBP Covid-19 Task Team Members,

Hope all are well. Please see the link and agenda below for our last meeting on September 8th. Looking forward to it!

Join Zoom Meeting
https://us02web.zoom.us/j/81278836310?pwd=MVVabzkzSjhWODhybHVxWWVuVjIydz09

Meeting ID: 812 7883 6310
Passcode: 245557

[cid:image003.jpg@...]


Agenda:

* Key themes from the COVID-19 and FP/RH Story Map (FHI360)
* FP program adaptations during the COVID-19 pandemic (FHI360)
* Small group discussions on policy, SBC and service delivery adaptations (All)

________________________________

Dear IBP Covid-19 Task Team Members,

Hope all are well. We would like to organize one last Covid-19 Task Team Meeting in September. After much discussion and input from many of you, and given that Covid-19 continues to impact our daily work with many more resources available, it seems like a dedicated Task Team may no longer be required at this time. Our original "Tasks", of sharing updates on new guidance, program adaptations, and sharing Covid-19 response experiences has been met.

We can of course continue to share information and resources using the listserv (covid19@...<mailto:covid19@...>) and platform (https://ibpnetwork.org/topics/18248/feed) and if we feel the need to convene again in the future in a more formal way we can.

Looking forward to touching base in September and hope to keep the sharing going. Agenda and Zoom link to follow in the coming weeks.

With best wishes,

Nandita, Anne, Sarah, Trinity, on behalf of the Covid-19 Task Team


Save the Date: IBP Covid-19 and FP/RH Task Team

Nandita Thatte
 

Dear IBP Covid-19 Task Team Members,

Hope all are well. We would like to organize one last Covid-19 Task Team Meeting in September. After much discussion and input from many of you, and given that Covid-19 continues to impact our daily work with many more resources available, it seems like a dedicated Task Team may no longer be required at this time. Our original "Tasks", of sharing updates on new guidance, program adaptations, and sharing Covid-19 response experiences has been met.

We can of course continue to share information and resources using the listserv (covid19@...<mailto:covid19@...>) and platform (https://ibpnetwork.org/topics/18248/feed) and if we feel the need to convene again in the future in a more formal way we can.

Looking forward to touching base in September and hope to keep the sharing going. Agenda and Zoom link to follow in the coming weeks.

With best wishes,

Nandita, Anne, Sarah, Trinity, on behalf of the Covid-19 Task Team


Webinar Thursday June 24, 9hEST/13hGMT/15hCEST: Covid-19 and FP Program Adaptations in Francophone West Africa: Updates and Steps for the Future

Nandita Thatte
 

Dear IBP Colleagues,

On behalf of the IBP Covid-19 and FP/RH Task Team, please join us next Thursday June 24th at 9amEST/13hGMT/15hCEST for a webinar featuring updates on Family Planning Program Adaptations from Francophone West Africa. We will showcase experiences from the region and provide an opportunity to discuss implications for future programming.

The webinar will be in French with simultaneous English interpretation.

Register Here: https://us02web.zoom.us/webinar/register/WN_A9PqghD2QOeileOK-pQiuA

[cid:image005.jpg@...]


Also be sure to check out the Interactive Map of FP Adaptations during Covid-19 and add your Input!

https://ibpnetwork.org/page/fp-covid-19-interactive-map



[cid:image004.jpg@...]<https://ibpnetwork.org/page/fp-covid-19-interactive-map>


Nandita Thatte, DrPH
Department of Sexual and Reproductive Health
World Health Organization
Geneva, Switzerland
Email: thatten@...<mailto:thatten@...>
www.ibpnetwork.org<http://www.who.int/reproductivehealth>

[cid:image003.png@...]


IBP COVID-19 Task Team Assessment

anne.ballard@...
 

Dear COVID FP/RH Task Team Members,

 

The WHO/IBP Network, Knowledge SUCCESS and Research for Scalable Solutions formed the COVID-19 and Family Planning/Reproductive Health Task Team in April of 2020 to create a space to discuss challenges faced by family planning stakeholders during the pandemic. 

 

Now, over one year in, we’d like your input to determine whether and how this Task Team continues to function. It should only take you about 5 minutes to complete. Please submit your responses by June 10. Thank you in advance!

 

https://www.surveymonkey.com/r/IBPTaskTeam

 

Sincerely,

The Task Team Chairs

 

-

Le réseau OMS/IBP et les projets Knowledge SUCCESS et Research for Scalable Solutions ont formé l'équipe de travail pour le COVID-19 et le planning familial/santé reproductive en avril 2020 afin de créer un espace pour discuter des défis auxquels sont confrontés les acteurs du planning familial pendant la pandémie. 

 

Aujourd'hui, plus d'un an après, nous aimerions avoir votre avis pour déterminer si et comment ce groupe de travail continue à fonctionner, ce qui ne devrait vous prendre qu'environ 5 minutes. Veuillez soumettre vos réponses avant le 10 juin.

 

https://www.surveymonkey.com/r/lequipedetravail

 

-

La Red de la OMS/IBP, Knowledge SUCCESS y Research for Scalable Solutions formaron el Equipo de Trabajo sobre el COVID-19 y la Planificación Familiar/Salud Reproductiva en abril de 2020 para crear un espacio en el que debatir los retos a los que se enfrentan las partes interesadas en la planificación familiar durante la pandemia. 

 

Ahora, después de más de un año, nos gustaría conocer su opinión para determinar si este Equipo de Trabajo sigue funcionando y cómo lo hace. Envíe sus respuestas antes del 10 de junio.

 

https://www.surveymonkey.com/r/IBPEquipodeTrabajo

 

 

 

Anne Ballard Sara

Program Officer II, Knowledge SUCCESS

 

Johns Hopkins Center for Communication Programs

111 Market Place, Suite 310

Baltimore, MD 21202

Email: Anne.ballard@...

Skype: anneballard.ccp

Website: https://ccp.jhu.edu/ | https://knowledgesuccess.org/

Pronouns: she/her

 

 

 

 


FW: NEW: COVID-19 Vaccine Resources

Nandita Thatte
 

FYI...

From: Franca Etienne <crd_partners@...>
Sent: Tuesday, May 18, 2021 1:06 PM
To: THATTE, Nandita <thatten@...>
Subject: [EXT] NEW: COVID-19 Vaccine Resources


COVID-19 Vaccine Introduction Updates
‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌

No images? Click here<https://crdpartners.cmail20.com/t/d-e-qikditl-tdlkujgdr-dd/>
[World Health Organization]<https://crdpartners.cmail20.com/t/d-l-qikditl-tdlkujgdr-r/>
[A vaccination team goes door-to-door in a working class neighbourhood of Puerto Inirida, Colombia.]<https://crdpartners.cmail20.com/t/d-l-qikditl-tdlkujgdr-y/>

New COVID-19 vaccine resources

As we gear towards the 74th World Health Assembly<https://crdpartners.cmail20.com/t/d-l-qikditl-tdlkujgdr-j/>, which will take place virtually from 24 May to 1 June 2021 in light of the ongoing COVID-19 pandemic, we reflect on the progress made in terms of vaccines introduction and roll-out. More than 120 COVAX participants have now received at least one shipment of COVID-19 vaccines, with over 58.2 million doses delivered as of 11 May. These achievements were only possible due to the unwavering commitment by partners and immunization professionals around the world.

Please see below some recently published updates to the COVID-19 vaccine introduction toolkit<https://crdpartners.cmail20.com/t/d-l-qikditl-tdlkujgdr-t/>, which is available in AR<https://crdpartners.cmail20.com/t/d-l-qikditl-tdlkujgdr-i/> CH<https://crdpartners.cmail20.com/t/d-l-qikditl-tdlkujgdr-d/> EN<https://crdpartners.cmail20.com/t/d-l-qikditl-tdlkujgdr-h/> FR<https://crdpartners.cmail20.com/t/d-l-qikditl-tdlkujgdr-k/> RU<https://crdpartners.cmail20.com/t/d-l-qikditl-tdlkujgdr-u/> SP<https://crdpartners.cmail20.com/t/d-l-qikditl-tdlkujgdr-o/>.



[Rectangle: Rounded Corners: LEARN HOW TO INTRODUCE COVID-19 VACCINES]


[COVID-19 Vaccine Introduction and deployment Costing tool (‎‎‎‎CVIC tool)]<https://crdpartners.cmail20.com/t/d-l-qikditl-tdlkujgdr-n/>

Updated CVIC tool

The COVID-19 Vaccine Introduction and deployment Costing Tool (CVIC tool)<https://crdpartners.cmail20.com/t/d-l-qikditl-tdlkujgdr-p/> supports credible COVID-19 vaccination costing to facilitate a dialogue with stakeholders, while maintaining sensitivity to protecting essential health services. It provides a structured and comprehensive estimation of incremental operational and selected capital costs of introducing and deploying COVID-19 vaccines, in alignment with the National Deployment and Vaccination Plan (NDVP)<https://crdpartners.cmail20.com/t/d-l-qikditl-tdlkujgdr-x/>. This is essential for resource mobilization, budgeting, and delivery strategy refinement and optimization.

The tool has been pre-populated with data from global databases and provides a total cost estimate for an immunization programme over the period of 2021-2023, after which COVID-19 vaccination is expected to be integrated into national immunization plans.

Countries can customize the priority target populations based on the WHO SAGE guidance <https://crdpartners.cmail20.com/t/d-l-qikditl-tdlkujgdr-m/> and select multiple delivery strategies and vaccine products. The tool is available in all six UN languages (Arabic, Chinese, English, French, Russian and Spanish) and Portuguese.

Countries can submit their resource needs onto the WHO COVID-19 Partners Platform <https://crdpartners.cmail20.com/t/d-l-qikditl-tdlkujgdr-v/> by either uploading a completed CVIC 2.1 tool excel spreadsheet or manually entering their resource needs. The cost categories for technical assistance and funding resource requests through the platform are harmonized into the nine common costing categories outlined in the NDVP Guidance 2.0.

Learn more about vaccines costing and funding<https://crdpartners.cmail20.com/t/d-l-qikditl-tdlkujgdr-e/>

[A nurse prepares a COVID-19 vaccine dose.]<https://crdpartners.cmail20.com/t/d-l-qikditl-tdlkujgdr-s/>

No-fault Compensation Program

The COVAX No-Fault Compensation Program for AMC-Eligible Economies (the “Program”) has been operational since 31 March 2021. The Program’s Protocol (procedure) and Forms – including application and other forms – as well as other relevant Program information and resources are available in English, French and Spanish on the Program’s web portal<https://crdpartners.cmail20.com/t/d-l-qikditl-tdlkujgdr-g/>, which also has instructions on how to submit an application and detailed FAQs to guide interested applicants.

ESIS Inc. will not charge any fees to Program applicants. Eligible individuals will have ample time to apply for compensation under the Program including if a COVAX-distributed vaccine was administered to them before the Program became operational on 31 March 2021.

COVAX No-Fault Compensation Program for AMC-Eligible Economies<https://crdpartners.cmail20.com/t/d-l-qikditl-tdlkujgdr-w/>

[COVID-19 vaccinators plan immunization campaign.]<https://crdpartners.cmail20.com/t/d-l-qikditl-tdlkujgdr-yd/>

Vaccine specific updates

The AstraZeneca vaccine explainer<https://crdpartners.cmail20.com/t/d-l-qikditl-tdlkujgdr-yh/> has been updated according to Emergency Use Listing and SAGE recommendations.

The short Janssen vaccine instructional video<https://crdpartners.cmail20.com/t/d-l-qikditl-tdlkujgdr-yk/> and the training video on how to identify and manage anaphylaxis<https://crdpartners.cmail20.com/t/d-l-qikditl-tdlkujgdr-yu/> are now available online.

Read more about vaccine specific resources<https://crdpartners.cmail20.com/t/d-l-qikditl-tdlkujgdr-jl/>


Have questions or suggestions?



[Rectangle: Rounded Corners: SEND US AN E-MAIL]


[Vaccinator examines vial.]<https://crdpartners.cmail20.com/t/d-l-qikditl-tdlkujgdr-jr/>
Extra doses in a vial

Please check out the job aide that explains Why are there extra doses of vaccine in the vaccine vial?<https://crdpartners.cmail20.com/t/d-l-qikditl-tdlkujgdr-jy/> and provides guidance for their use. Currently available in: AR<https://crdpartners.cmail20.com/t/d-l-qikditl-tdlkujgdr-jj/> CH<https://crdpartners.cmail20.com/t/d-l-qikditl-tdlkujgdr-jt/> EN<https://crdpartners.cmail20.com/t/d-l-qikditl-tdlkujgdr-ji/> RU<https://crdpartners.cmail20.com/t/d-l-qikditl-tdlkujgdr-jd/> SP<https://crdpartners.cmail20.com/t/d-l-qikditl-tdlkujgdr-jh/>.

[A nurse completes a vaccination sticker with the time the patient receives the vaccine.]<https://crdpartners.cmail20.com/t/d-l-qikditl-tdlkujgdr-jk/>
Supportive supervision

You can review the Supportive supervision for COVID-19 vaccination<https://crdpartners.cmail20.com/t/d-l-qikditl-tdlkujgdr-ju/> job aide, now available in AR<https://crdpartners.cmail20.com/t/d-l-qikditl-tdlkujgdr-tl/> CH<https://crdpartners.cmail20.com/t/d-l-qikditl-tdlkujgdr-tr/> EN<https://crdpartners.cmail20.com/t/d-l-qikditl-tdlkujgdr-ty/> FR<https://crdpartners.cmail20.com/t/d-l-qikditl-tdlkujgdr-tj/>.

[Clients rest after receiving COVID-19 vaccine at a maternity and women's hospital in Nepal.]<https://crdpartners.cmail20.com/t/d-l-qikditl-tdlkujgdr-tt/>
Communication flow

The communications flow diagram<https://crdpartners.cmail20.com/t/d-l-qikditl-tdlkujgdr-ti/> has been updated and now includes key messaging for pregnant women.

[Client receives a COVID-19 vaccine in Accra, Ghana.]<https://crdpartners.cmail20.com/t/d-l-qikditl-tdlkujgdr-td/>

Intra-action review

Intra-action review (also known as the mini COVID-19 Post Introduction Evaluation, or mini-cPIE) documents trigger question database<https://crdpartners.cmail20.com/t/d-l-qikditl-tdlkujgdr-th/>, note taking template<https://crdpartners.cmail20.com/t/d-l-qikditl-tdlkujgdr-tk/>, and report template<https://crdpartners.cmail20.com/t/d-l-qikditl-tdlkujgdr-tu/> are available in English.

Learn how to use these tools watching the Mini-cPIE (COVID-19 vaccination IAR) – What is it and how to conduct one?<https://crdpartners.cmail20.com/t/d-l-qikditl-tdlkujgdr-il/> training, in EN<https://crdpartners.cmail20.com/t/d-l-qikditl-tdlkujgdr-ir/> FR<https://crdpartners.cmail20.com/t/d-l-qikditl-tdlkujgdr-iy/> RU<https://crdpartners.cmail20.com/t/d-l-qikditl-tdlkujgdr-ij/> and SP<https://crdpartners.cmail20.com/t/d-l-qikditl-tdlkujgdr-it/>.

Check out the slide set<https://crdpartners.cmail20.com/t/d-l-qikditl-tdlkujgdr-ii/>, available in English.



[Client receives a COVID-19 vaccine in Accra, Ghana.]<https://crdpartners.cmail20.com/t/d-l-qikditl-tdlkujgdr-id/>

Training opportunities

Three more sessions remain for the national/sub-national audience of the COVID-19 Vaccination: Building Global Capacity webinars (Tuesdays, 12:00 – 13:00 CET), with live interpretation into French and Spanish.

Upcoming sessions:
· 18 May - Private Sector Engagement
· 01 June - Monitoring and Evaluating COVID-19 Vaccine Introduction
· 15 June - Adaptive leadership for COVID-19 Vaccine Introduction

Register for upcoming ECHO sessions here<https://crdpartners.cmail20.com/t/d-l-qikditl-tdlkujgdr-ih/>

Access session materials and recordings here<https://crdpartners.cmail20.com/t/d-l-qikditl-tdlkujgdr-ik/>

Access TechNet21 for webinar materials and discussion fora<https://crdpartners.cmail20.com/t/d-l-qikditl-tdlkujgdr-iu/>


Calling all volunteers

Do you work on health or immunization? Are you passionate about new and innovative approaches to improving vaccination coverage? If ‘yes’, then we’d like to hear from you!

WHO has developed a set of tools to support immunization programmes with the roll-out of COVID-19 vaccines and routine immunization strengthening. We are seeking critical and innovative thinkers to test these tools through telephone interviews in Angola, Ethiopia, India, Nigeria and Pakistan.

In partnership with research expert Kantar Public, WHO is looking to interview health professionals, programme managers, health officers and community volunteers involved in planning, delivering and/or advocating for immunization. Register your interest here<https://crdpartners.cmail20.com/t/d-l-qikditl-tdlkujgdr-dl/>! Please feel free to share this email with others who may be eligible and interested.

This work is part of a long-standing initiative to develop globally validated tools that support programmes to assess and address the social and behavioral drivers of immunization. This is a multi-partner initiative funded by Gavi and the Bill and Melinda Gates Foundation. If you’d like to hear more about this work, please do not hesitate to email Francine Ganter-Restrepo: ganterf@...<mailto:ganterf@...>.

[Nurses take a photo after COVID-19 vaccine in Manila, Philippines.]<https://crdpartners.cmail20.com/t/d-l-qikditl-tdlkujgdr-dr/>

Protection against violence

The Joint Note on Means to Protect Health Care from Acts of Violence in the COVID-19 Vaccination Roll-out in Fragile, Conflict-affected and Vulnerable Settings<https://crdpartners.cmail20.com/t/d-l-qikditl-tdlkujgdr-dy/> is now available online.

[Facebook]<https://crdpartners.cmail20.com/t/d-l-qikditl-tdlkujgdr-dj/>[Twitter]<https://crdpartners.cmail20.com/t/d-l-qikditl-tdlkujgdr-dt/>[Website]<https://crdpartners.cmail20.com/t/d-l-qikditl-tdlkujgdr-di/>



Please share this message with colleagues and networks.

If others would like to join our distribution list, please email: francae@...<mailto:francae@...>


COVAX Country Readiness and Delivery (CRD) Workstream
Preferences<https://crdpartners.updatemyprofile.com/d-qikditl-64501725-tdlkujgdr-dh> | Unsubscribe<https://crdpartners.cmail20.com/t/d-u-qikditl-tdlkujgdr-dk/>


FW: NEW! COVID-19 vaccine introduction toolkit in all UN languages

Nandita Thatte
 

FYI...

From: CRDPARTNERS <CRDPARTNERS@...> On Behalf Of FRANCA, Etienne
Sent: Tuesday, March 30, 2021 9:30 AM
To: CRDPARTNERS@...
Subject: NEW! COVID-19 vaccine introduction toolkit in all UN languages

[Version française disponible ci-dessous]

ENGLISH

Dear colleague,

The COVID-19 vaccine introduction toolkit<https://www.who.int/tools/covid-19-vaccine-introduction-toolkit> is now available in all UN languages: Arabic<https://www.who.int/ar/toolkits/covid-19-vaccine-introduction-toolkit>, Chinese<https://www.who.int/zh/toolkits/covid-19-vaccine-introduction-toolkit>, French<https://www.who.int/fr/toolkits/covid-19-vaccine-introduction-toolkit>, Russian<https://www.who.int/ru/toolkits/covid-19-vaccine-introduction-toolkit> and Spanish<https://www.who.int/es/toolkits/covid-19-vaccine-introduction-toolkit>. We will update these pages as more resources become available. For questions, comments or feedback, please e-mail: COVID19vaccineresources@...<mailto:COVID19vaccineresources@...>.

Please check out these new resources added to the Toolkit to support COVID-19 vaccination:

COVID-19 Vaccine Specific Resources


· The OpenWHO COVID-19 vaccine-specific resources course is now available in EN<https://openwho.org/courses/COVID-19-vaccines> CH<https://openwho.org/courses/covid-19-vaccines-zh> RU<https://openwho.org/courses/COVID-19-vaccines-ru>



You can also watch the videos from the COVID-19 vaccine specific resources course on how to handle, prepare, and administer COVID-19 vaccines here:

o AstraZeneca ChAdOx1-S/nCoV-19 [recombinant] COVID-19 vaccine training video<https://watch.immunizationacademy.com/en/videos/763> (5 min)

o Moderna mRNA-1273 COVID-19 vaccine training video<https://watch.immunizationacademy.com/en/videos/762> (6 min)

o Pfizer Comirnaty Tozinameran training video<https://watch.immunizationacademy.com/en/videos/759> (7 min)

o Recognizing Anaphylaxis training video<https://watch.immunizationacademy.com/en/videos/760> (4 min)



· The Janssen (Johnson and Johnson) vaccine explainer<https://www.who.int/publications/m/item/janssen-ad26.cov2-s-recombinant-covid-19-vaccine> is now available.


* Considerations for optimizing deployment of AstraZeneca/AZD1222 and SII/Covishield vaccines in a time-limited constrained supply situation<https://www.who.int/publications/m/item/considerations-for-optimizing-deployment-of-astrazeneca-azd1222-and-sii-covishield-vaccines-in-a-time-limited-constrained-supply-situation> provides an overview of programmatic considerations to guide national decision-making.

COVID-19 Vaccine Effectiveness Guidance


* Vaccine effectiveness and impact guidance<https://www.who.int/publications/i/item/WHO-2019-nCoV-vaccine_effectiveness-measurement-2021.1> and its accompanying sample size calculator<https://www.who.int/publications/i/item/WHO-2019-nCoV-vaccine_effectiveness-measurement_tool-2021.1> provide interim guidance on how to assess COVID-19 vaccine effectiveness. It discusses critical considerations in the design, analysis and interpretation of vaccine effectiveness evaluations to avoid biased results.


COVID-19 Vaccination Capacity Training Resources


* The Health Worker COVID-19 Vaccination course is now available in various languages: AR<https://eur01.safelinks.protection.outlook.com/?url=https%3A%2F%2Fopenwho.org%2Fcourses%2Fcovid-19-vaccination-healthworkers-ar&data=04%7C01%7Coakturan%40gavi.org%7C0ed208a478cf492576a308d8dfbd5da7%7C1de6d9f30daf4df6b9d65959f16f6118%7C0%7C0%7C637505351717963954%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C1000&sdata=gBdILYJQYBIofOokJwbDIrQ%2FPm4KCiHKZ42gKNHrnho%3D&reserved=0> CH<https://eur01.safelinks.protection.outlook.com/?url=https%3A%2F%2Fopenwho.org%2Fcourses%2Fcovid-19-vaccination-healthworkers-zh&data=04%7C01%7Coakturan%40gavi.org%7C0ed208a478cf492576a308d8dfbd5da7%7C1de6d9f30daf4df6b9d65959f16f6118%7C0%7C0%7C637505351717963954%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C1000&sdata=3ccwF9S9aSpB%2BGRqSyI81qSuGvuBHtE5%2F8iSuChYKWA%3D&reserved=0> EN<https://openwho.org/courses/covid-19-vaccination-healthworkers-en> FR<https://openwho.org/courses/covid-19-vaccination-personnel-de-sante-fr> RU<https://eur01.safelinks.protection.outlook.com/?url=https%3A%2F%2Fopenwho.org%2Fcourses%2Fcovid-19-vaccination-healthworkers-ru&data=04%7C01%7Coakturan%40gavi.org%7C0ed208a478cf492576a308d8dfbd5da7%7C1de6d9f30daf4df6b9d65959f16f6118%7C0%7C0%7C637505351717983942%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C1000&sdata=aUXpbyz5EYVMSn%2FPpKavRpA4xekzLr%2FDDgDuqPh1Ne8%3D&reserved=0> SP<https://openwho.org/courses/covid-19-vacunacion-personalsanitarios-es> and also in Dutch<https://openwho.org/courses/COVID-19-vaccinatie-gezondheidswerkers>, Indonesian<https://eur01.safelinks.protection.outlook.com/?url=https%3A%2F%2Fopenwho.org%2Fcourses%2Fcovid-19-vaksinasi-tenagakesehatan&data=04%7C01%7Coakturan%40gavi.org%7C0ed208a478cf492576a308d8dfbd5da7%7C1de6d9f30daf4df6b9d65959f16f6118%7C0%7C0%7C637505351717973943%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C1000&sdata=qfJhzQFT9tCs1%2FeEhqOGqv1XScQFSzM8PD9wS4SpmLs%3D&reserved=0>, Macedonian<https://eur01.safelinks.protection.outlook.com/?url=https%3A%2F%2Fopenwho.org%2Fcourses%2Fcovid-19-vaccination-healthworkers-mk&data=04%7C01%7Coakturan%40gavi.org%7C0ed208a478cf492576a308d8dfbd5da7%7C1de6d9f30daf4df6b9d65959f16f6118%7C0%7C0%7C637505351717973943%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C1000&sdata=0ceiYq0C0wb%2BuOPMpHiYy2%2BSAbVfx0gpyKNEj1%2BAI0k%3D&reserved=0>, and Vietnamese<https://eur01.safelinks.protection.outlook.com/?url=https%3A%2F%2Fopenwho.org%2Fcourses%2Fcovid-19-vaccination-healthworkers-vi&data=04%7C01%7Coakturan%40gavi.org%7C0ed208a478cf492576a308d8dfbd5da7%7C1de6d9f30daf4df6b9d65959f16f6118%7C0%7C0%7C637505351717983942%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C1000&sdata=eR1PD%2FBoXB9zg3q264coJiRqtTLBpzd24YSglppTSUQ%3D&reserved=0>. If you’d like to request access to the presentations, please email COVID19vaccineresources@...<mailto:COVID19vaccineresources@...>.


* The COVID-19 immunization checklist, an important job aid for health workers, is also available in new language versions. AR<https://www.who.int/docs/default-source/coronaviruse/act-accelerator/covax/21109_arabic-covid-19-vaccination-checklist.pdf?sfvrsn=7f4b7a3f_5> EN<https://www.who.int/publications/m/item/covid-19-vaccine-checklist> FR<https://www.who.int/docs/default-source/coronaviruse/act-accelerator/covax/21124_french-covid-19-vaccination-checklist.pdf?sfvrsn=40c1af92_5> RU<https://www.who.int/docs/default-source/coronaviruse/act-accelerator/covax/21110_russian-covid-19-vaccination-checklist.pdf?sfvrsn=350ad4ed_5> SP<https://www.who.int/docs/default-source/coronaviruse/act-accelerator/covax/21122_spanish-covid-19-vaccination-checklist.pdf?sfvrsn=50621201_5> PT<https://www.who.int/docs/default-source/coronaviruse/act-accelerator/covax/21123_portugues-covid-19-vaccination-checklist.pdf?sfvrsn=2e1a5a27_5>


· The COVID-19 Vaccination: Building Global Capacity webinars continue every Tuesday from 12:00 to 13:00 CET (interpretation into French and Spanish). Webinar materials are available through TechNet-21<https://www.technet-21.org/en/topics/covid-19-vaccine>. For registration links and additional resources, please visit the Project ECHO website<https://hsc.unm.edu/echo/institute-programs/covid-19-response/international-covid19/who-collaborations/act-accelerator.html>.


Date

Audience

Topic

Registration

30 Mar

Health Workers

Reporting on COVID-19 vaccines (monitoring and AEFI)

https://echo.zoom.us/webinar/register/WN_81Wgk82kRcmmMVJ43SNOuA



6 Apr

National/Subnational

Vaccination strategies for COVID-19 vaccination

https://echo.zoom.us/webinar/register/WN_60QBnRtURmaoXz2mGFWPIQ



13 Apr

Health Workers

Supply and logistics

https://echo.zoom.us/webinar/register/WN_81Wgk82kRcmmMVJ43SNOuA



20 Apr

National/Subnational

Mobilizing financing resources to scale-up COVID-19 vaccination

https://echo.zoom.us/webinar/register/WN_60QBnRtURmaoXz2mGFWPIQ



Please feel free to share this message with your colleagues and networks.



FRANÇAIS

Nous vous avons inclus dans notre liste de diffusion car vous avez un rôle clé dans le déploiement de la vaccination contre la COVID-19. Vous pouvez vous désabonner de cette liste en cliquant sur le lien au bas de ce message.

Chère/cher collègue,

Le Dossier pour la mise en place de la vaccination anti-COVID-19<https://www.who.int/fr/toolkits/covid-19-vaccine-introduction-toolkit> est disponible dans toutes les langues de l'ONU : anglais<https://www.who.int/tools/covid-19-vaccine-introduction-toolkit>, arabe<https://www.who.int/ar/toolkits/covid-19-vaccine-introduction-toolkit>, chinois<https://www.who.int/zh/toolkits/covid-19-vaccine-introduction-toolkit>, français<https://www.who.int/fr/toolkits/covid-19-vaccine-introduction-toolkit>, espagnol<https://www.who.int/es/toolkits/covid-19-vaccine-introduction-toolkit> et russe<https://www.who.int/ru/toolkits/covid-19-vaccine-introduction-toolkit>. Nous mettrons ces pages à jour au fur et à mesure que de nouvelles ressources seront disponibles. Pour toute question ou commentaire, veuillez envoyer un message à : COVID19vaccineresources@...<mailto:COVID19vaccineresources@...>.

Veuillez consulter les nouvelles ressources récemment ajoutées au Dossier pour soutenir la vaccination anti-COVID-19 :

Ressources sur les vaccins contre la COVID-19


· Le Cours de ressources spécifiques au vaccin COVID-19 sur OpenWHO est disponible en AN<https://openwho.org/courses/COVID-19-vaccines> CH<https://openwho.org/courses/covid-19-vaccines-zh> RU<https://openwho.org/courses/COVID-19-vaccines-ru>

Vous pouvez aussi accéder à des courtes vidéos didactiques de ce cours sur la manipulation, la préparation et l'administration des vaccins AstraZeneca, Pfizer et Moderna ici (en anglais) :

* Vidéo de formation sur le vaccin AstraZeneca ChAdOx1-S / nCoV-19 [recombinant] COVID-19<https://watch.immunizationacademy.com/en/videos/763> (5 min)
* Vidéo de formation sur le vaccin Moderna mRNA-1273 COVID-19<https://watch.immunizationacademy.com/en/videos/762> (6 min)
* Vidéo de formation Pfizer Comirnaty Tozinameran<https://watch.immunizationacademy.com/en/videos/759> (7 min)
* Vidéo de formation sur la reconnaissance de l'anaphylaxie<https://watch.immunizationacademy.com/en/videos/760> (4 min)


· L'Explication du vaccin Janssen (Johnson et Johnson)<https://www.who.int/publications/m/item/janssen-ad26.cov2-s-recombinant-covid-19-vaccine> est disponible en anglais.


· Les Considérations relatives à l'optimisation du déploiement des vaccins AstraZeneca / AZD1222 et SII / Covishield dans une situation d'approvisionnement limité<https://www.who.int/publications/m/item/considerations-for-optimizing-deployment-of-astrazeneca-azd1222-and-sii-covishield-vaccines-in-a-time-limited-constrained-supply-situation> donnent un aperçu des considérations programmatiques pour guider la prise de décision nationale. (En anglais)

Orientation sur l’efficacité des vaccins contre la COVID-19


· Les Directives sur l'efficacité et l'impact des vaccins<https://www.who.int/publications/i/item/WHO-2019-nCoV-vaccine_effectiveness-measurement-2021.1> et son calculateur de la taille de l'échantillon<https://www.who.int/publications/i/item/WHO-2019-nCoV-vaccine_effectiveness-measurement-2021.1> fournissent des conseils provisoires sur la façon d'évaluer l'efficacité du vaccin COVID-19. Ces ressources discutent des considérations critiques dans la conception, l'analyse et l'interprétation des évaluations de l'efficacité des vaccins afin d'éviter des résultats biaisés. (En anglais)

Ressources pour la formation à la vaccination contre la COVID-19


* Le Cours de vaccination COVID-19 pour les agents de santé est désormais disponible en plusieurs langues: AR<https://eur01.safelinks.protection.outlook.com/?url=https%3A%2F%2Fopenwho.org%2Fcourses%2Fcovid-19-vaccination-healthworkers-ar&data=04%7C01%7Coakturan%40gavi.org%7C0ed208a478cf492576a308d8dfbd5da7%7C1de6d9f30daf4df6b9d65959f16f6118%7C0%7C0%7C637505351717963954%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C1000&sdata=gBdILYJQYBIofOokJwbDIrQ%2FPm4KCiHKZ42gKNHrnho%3D&reserved=0> CH<https://eur01.safelinks.protection.outlook.com/?url=https%3A%2F%2Fopenwho.org%2Fcourses%2Fcovid-19-vaccination-healthworkers-zh&data=04%7C01%7Coakturan%40gavi.org%7C0ed208a478cf492576a308d8dfbd5da7%7C1de6d9f30daf4df6b9d65959f16f6118%7C0%7C0%7C637505351717963954%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C1000&sdata=3ccwF9S9aSpB%2BGRqSyI81qSuGvuBHtE5%2F8iSuChYKWA%3D&reserved=0> AN<https://openwho.org/courses/covid-19-vaccination-healthworkers-en> FR<https://openwho.org/courses/covid-19-vaccination-personnel-de-sante-fr> RU<https://eur01.safelinks.protection.outlook.com/?url=https%3A%2F%2Fopenwho.org%2Fcourses%2Fcovid-19-vaccination-healthworkers-ru&data=04%7C01%7Coakturan%40gavi.org%7C0ed208a478cf492576a308d8dfbd5da7%7C1de6d9f30daf4df6b9d65959f16f6118%7C0%7C0%7C637505351717983942%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C1000&sdata=aUXpbyz5EYVMSn%2FPpKavRpA4xekzLr%2FDDgDuqPh1Ne8%3D&reserved=0> ES<https://openwho.org/courses/covid-19-vacunacion-personalsanitarios-es> et également en néerlandais<https://openwho.org/courses/COVID-19-vaccinatie-gezondheidswerkers>, indonésien<https://eur01.safelinks.protection.outlook.com/?url=https%3A%2F%2Fopenwho.org%2Fcourses%2Fcovid-19-vaksinasi-tenagakesehatan&data=04%7C01%7Coakturan%40gavi.org%7C0ed208a478cf492576a308d8dfbd5da7%7C1de6d9f30daf4df6b9d65959f16f6118%7C0%7C0%7C637505351717973943%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C1000&sdata=qfJhzQFT9tCs1%2FeEhqOGqv1XScQFSzM8PD9wS4SpmLs%3D&reserved=0>, macédonien<https://eur01.safelinks.protection.outlook.com/?url=https%3A%2F%2Fopenwho.org%2Fcourses%2Fcovid-19-vaccination-healthworkers-mk&data=04%7C01%7Coakturan%40gavi.org%7C0ed208a478cf492576a308d8dfbd5da7%7C1de6d9f30daf4df6b9d65959f16f6118%7C0%7C0%7C637505351717973943%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C1000&sdata=0ceiYq0C0wb%2BuOPMpHiYy2%2BSAbVfx0gpyKNEj1%2BAI0k%3D&reserved=0> et vietnamien<https://eur01.safelinks.protection.outlook.com/?url=https%3A%2F%2Fopenwho.org%2Fcourses%2Fcovid-19-vaccination-healthworkers-vi&data=04%7C01%7Coakturan%40gavi.org%7C0ed208a478cf492576a308d8dfbd5da7%7C1de6d9f30daf4df6b9d65959f16f6118%7C0%7C0%7C637505351717983942%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C1000&sdata=eR1PD%2FBoXB9zg3q264coJiRqtTLBpzd24YSglppTSUQ%3D&reserved=0>. Si vous souhaitez accéder aux présentations, veuillez envoyer un email à COVID19vaccineresources@...<mailto:COVID19vaccineresources@...>.


· La Liste de contrôle de la vaccination contre la COVID-19, un outil de travail important pour les agents de santé, est également disponible dans de nouvelles langues. AR<https://www.who.int/docs/default-source/coronaviruse/act-accelerator/covax/21109_arabic-covid-19-vaccination-checklist.pdf?sfvrsn=7f4b7a3f_5> AN<https://www.who.int/publications/m/item/covid-19-vaccine-checklist> FR<https://www.who.int/docs/default-source/coronaviruse/act-accelerator/covax/21124_french-covid-19-vaccination-checklist.pdf?sfvrsn=40c1af92_5> RU<https://www.who.int/docs/default-source/coronaviruse/act-accelerator/covax/21110_russian-covid-19-vaccination-checklist.pdf?sfvrsn=350ad4ed_5> ES<https://www.who.int/docs/default-source/coronaviruse/act-accelerator/covax/21122_spanish-covid-19-vaccination-checklist.pdf?sfvrsn=50621201_5> PT<https://www.who.int/docs/default-source/coronaviruse/act-accelerator/covax/21123_portugues-covid-19-vaccination-checklist.pdf?sfvrsn=2e1a5a27_5>


· Les Webinaires sur la vaccination contre la COVID-19 : Renforcement des capacités mondiales se poursuivent tous les mardis de 12h00 à 13h00 CET (interprétation en français et en espagnol). Le contenu des webinaires est disponible via TechNet-21<https://www.technet-21.org/en/topics/covid-19-vaccine>. Pour les liens d'inscription et les ressources supplémentaires, veuillez visiter le site Web du projet ECHO<https://hsc.unm.edu/echo/institute-programs/covid-19-response/international-covid19/who-collaborations/act-accelerator.html>.


Date

Audience

Topic

Registration

30 Mars

Agents de santé

Rapports sur les vaccins contre la COVID-19 (surveillance et ​Manifestions post-vaccinales indésirables - MAPI)

https://echo.zoom.us/webinar/register/WN_81Wgk82kRcmmMVJ43SNOuA



6 Avril

National/Sous-national

Stratégies nationales de vaccination pour la vaccination contre la COVID-1919 vaccination

https://echo.zoom.us/webinar/register/WN_60QBnRtURmaoXz2mGFWPIQ



13 Avril

Agents de santé

Approvisionnement et logistique

https://echo.zoom.us/webinar/register/WN_81Wgk82kRcmmMVJ43SNOuA



20 Avril

National/Sous-national

Mobilisation des ressources financières pour l'intensification de la vaccination contre la COVID-19

https://echo.zoom.us/webinar/register/WN_60QBnRtURmaoXz2mGFWPIQ



N'hésitez pas à partager ce message avec vos collègues et vos réseaux.



Best regards,

Etienne Franca
Consultant
Communications, Advocacy, and Training Working Group
Country Readiness and Delivery for COVID-19 Vaccine introduction
WHO/WHE/IHM/IPR - HQ
Mobile: +351 910 775 772 | +1 203 768 3104
Web: www.who.int<https://www.who.int> – CRD webpage<https://www.who.int/initiatives/act-accelerator/covax/covid-19-vaccine-country-readiness-and-delivery>
Follow WHO on Facebook<https://www.facebook.com/WHO/> | Twitter<https://twitter.com/WHO> | YouTube<https://www.youtube.com/user/who> | Instagram<https://www.instagram.com/who/>

[signature_1613535319]


[signature_961503508]




________________________________

To unsubscribe from the CRDPARTNERS list, click the following link:
http://listserv.who.int/scripts/wa.exe?TICKET=NzM3OTA5IHRoYXR0ZW5AV0hPLklOVCBDUkRQQVJUTkVSU0Dho8BbafV5&c=SIGNOFF


Webinar March 23: Generating acceptance and demand for COVID-19 vaccines/ supporting community led activities and reaching key influencers

Nandita Thatte
 

Dear IBP Covid-19 and FP Task Team Colleagues,

In lieu of our regular meeting, please join the webinar next week hosted by the WHO Covid-19 Vaccine Introduction Group. The topic is: Generating acceptance and demand for COVID-19 vaccines/ supporting community led activities and reaching key influencers.

The webinar will be available in English with Interpretation French, Spanish, and other UN languages.

Register Here:
https://echo.zoom.us/webinar/register/WN_60QBnRtURmaoXz2mGFWPIQ

Thanks, Nandita



Nandita Thatte, DrPH
Sexual and Reproductive Health and Research
Geneva, Switzerland
Email: thatten@...<mailto:thatten@...>
Web: www.ibpnetwork.org<http://www.ibpnetwork.org>
Web: www.who.int<https://www.who.int>
Follow WHO on Facebook<https://www.facebook.com/WHO/> | Twitter<https://twitter.com/WHO> | YouTube<https://www.youtube.com/user/who> | Instagram<https://www.instagram.com/who/>

[cid:image002.jpg@...]

[Graphical user interface, application Description automatically generated]


Register Now! WEBINAR 3/17 - Data Use in COVID-19 Response

Ados May
 

 

 

 

WEBINAR

Join the Health Systems Strengthening Accelerator (Accelerator) and the Joint Learning Network for Universal Health Coverage (JLN) for a webinar with experts from around the world as they share how they are using data to shape their understanding of the spread of COVID-19, including available technology, national coordination, and interoperability. Panelists will draw out successes, challenges, and best practices, including a discussion of how COVID-19 investments can be leveraged to strengthen data availability and responsiveness in shaping evidence-based responses to COVID-19 and, across the health system.

 

Data Use in COVID-19 Response: Experiences from Bangladesh, Ghana, Kenya, and the Philippines


Wednesday, March 17, 2021

12:30 PM GMT | 8:30 AM EST

Register in advancehttp://bit.ly/3vbtWx5 

 

SPEAKERS

  • Kamaliah Noh, Senior Fellow, Results for Development (Introduction)
  • Dr. Shahadt Hossain Mahmud, Director General, Health Economics Unit, Ministry of Health and Family Welfare and Additional Secretary to the Government of Bangladesh
  • Dr. Anthony Ofosu, Deputy Director-General, Ghana Health Service
  • Dr. Isabel Maina, Head of Healthcare Financing, Ministry of Health Kenya, and Joint Learning Network for Universal Health Coverage Co-convenor
  • Dr. Mel Santillan, Medical Officer, Philippines’ National Health Insurance Program

 

 

This content is made possible by the generous support of the American people through the United States Agency for International Development (USAID) under the terms of the Cooperative Agreement No. 7200-AA-18CA-00037. The contents are the responsibility of the Health Systems Strengthening Accelerator program and do not necessarily reflect the views of USAID or the United States Government.

 


FW: New resources for COVID-19 vaccines introduction | Nouvelles ressources pour l'introduction des vaccins contre la COVID-19

Nandita Thatte
 

FYI...

From: CRDPARTNERS <CRDPARTNERS@...> On Behalf Of FRANCA, Etienne
Sent: Tuesday, March 9, 2021 11:28 AM
To: CRDPARTNERS@...
Subject: New resources for COVID-19 vaccines introduction | Nouvelles ressources pour l'introduction des vaccins contre la COVID-19

Version française disponible ci-dessous

ENGLISH

We have included you on our listserv as you have a key role in COVID-19 vaccination roll-out. You can unsubscribe from this list by clicking the link at the bottom of this message.

Dear colleague,

We are sharing the new resources available to support COVID-19 vaccines introduction. For these resources and more, please visit the COVID-19 vaccines introduction toolbox<https://www.who.int/tools/covid-19-vaccine-introduction-toolkit/>, which provides guidance, tools, and training to equip all countries to prepare for and implement COVID-19 vaccination. For questions, comments or feedback, please e-mail: COVID19vaccineresources@...<mailto:COVID19vaccineresources@...>.


* The Monitoring COVID-19 Vaccination guidance provides considerations for: minimum and optional data to collect as vaccines are being rolled out and delivered; key performance indicators and the anticipated use of these—to measure the performance of key components of the immunization system and to take corrective action when needed; and the use of information systems to collect, store, analyze, and disseminate any relevant information. EN<https://apps.who.int/iris/bitstream/handle/10665/339993/WHO-2019-nCoV-vaccination-monitoring-2021.1-eng.pdf>



* COVID-19 vaccination data are now available on the WHO Coronavirus (COVID-19) Dashboard: covid19.who.int<https://covid19.who.int/>. These data are viewed by selecting “Vaccination” from the dropdown panel on the left-hand side of the map. Currently, the dashboard incorporates information useful to track global vaccine roll-out, including total vaccination doses administered, persons vaccinated with at least one dose, and start date of vaccinations, by country, territory and area. More features (e.g., specifics on vaccine products authorized and administered and data downloads) will be added in the near future.



* The COVID-19 vaccine-specific resources<https://openwho.org/courses/COVID-19-vaccines> course has launched on OpenWHO! Further videos and resources concerning other vaccines that receive emergency use listing (EUL) or prequalification will be added shortly. This mini-course includes short instructional videos and vaccine explainers on the handling, preparation, and administration of COVID-19 vaccines such as:

· AstraZeneca: The AstraZeneca ChAdOx1-S/nCoV-19 [recombinant] vaccine resource includes key information on the vaccine specific requirements. EN<https://www.who.int/publications/m/item/chadox1-s-recombinant-covid-19-vaccine> CH<https://www.who.int/docs/default-source/coronaviruse/act-accelerator/covax/21089_chiniese_astrazeneca_vaccine-explainer.pdf?sfvrsn=622e9c36_5> FR<https://www.who.int/docs/default-source/coronaviruse/act-accelerator/covax/21098_french_astrazeneca_vaccine-explainer.pdf?sfvrsn=bf1f7d78_7> PT<https://www.who.int/docs/default-source/coronaviruse/act-accelerator/covax/21105_portuguese_astrazeneca_vaccine-explainer.pdf?sfvrsn=70445997_5> SP<https://www.who.int/docs/default-source/coronaviruse/act-accelerator/covax/21099_spanish_astrazeneca_vaccine-explainer.pdf?sfvrsn=f7250720_5>


* Moderna: The Moderna COVID-19 vaccine resource includes key information on the vaccine specific requirements. EN<https://www.who.int/publications/m/item/moderna-covid-19-vaccine-(mrna-1273)> CH<https://www.who.int/docs/default-source/coronaviruse/act-accelerator/covax/21081_chinese_moderna-vaccine-explainer.pdf?sfvrsn=7cee8939_5> FR<https://cdn.who.int/media/docs/default-source/immunization/covid-19/21074_french_moderna-vaccine-explainer_24-02-21.pdf?sfvrsn=398f7455_5> PT<https://www.who.int/docs/default-source/coronaviruse/act-accelerator/covax/21103_port_moderna-vaccine-explainer.pdf?sfvrsn=a30e4f_5>


* Pfizer/BioNTech: The Pfizer Comirnaty Tozinameran vaccine resource includes key information on the vaccine specific requirements. EN<https://www.who.int/publications/m/item/comirnaty-covid-19-mrna-vaccine> AR<https://cdn-auth-cms.who.int/media/docs/default-source/immunization/covid-19/21057_arabic_pfizer-vaccine-explainer_comirnaty_ar.pdf-65-.pdf?sfvrsn=16e275fb_8> CH<https://cdn-auth-cms.who.int/media/docs/default-source/immunization/covid-19/21040_chinese_vaccine-explainer_comirnaty-2.pdf?sfvrsn=271a9940_8> FR<https://cdn-auth-cms.who.int/media/docs/default-source/immunization/covid-19/21067_french_pfizer-vaccine-explainer_comirnaty.pdf?sfvrsn=4bda2d20_8> PT<https://cdn-auth-cms.who.int/media/docs/default-source/immunization/covid-19/21073_portuguese_pfizer-vaccine-explainer_comirnaty_24-02-21.pdf?sfvrsn=17e16e2b_3> RU<https://cdn-auth-cms.who.int/media/docs/default-source/immunization/covid-19/21053_russian_vaccine-explainer_comirnaty.pdf?sfvrsn=b003116d_8> SP<https://cdn.who.int/media/docs/default-source/immunization/covid-19/21066_spanish_pfizer-vaccine-explainer_comirnaty.pdf?sfvrsn=b2224120_10>

· More information is now available about the COVAX No-Fault Compensation (NFC) Program for AMC Eligible Economies. The Program will be operational by 31 March 2021, with a web portal available at www.covaxclaims.com<http://www.covaxclaims.com>. Further information about the Program is available through this presentation which provides an overview of the Program. EN<https://www.who.int/publications/m/item/covax-no-fault-compensation-program-for-amc-eligible-economies>

· The COVID-19 vaccine checklist for frontline health workers job aid helps health workers to prepare and complete a COVID-19 vaccination session at a fixed post or outreach session. EN<https://www.who.int/publications/m/item/covid-19-vaccine-checklist>

· The COVID-19 Vaccination: Building Global Capacity webinars held by WHO and partners continue every Tuesday from 12:00 to 13:00 CET (Interpretation into French and Spanish). You can watch the recordings of previous webinars and register for upcoming sessions here<https://hsc.unm.edu/echo/institute-programs/covid-19-response/international-covid19/who-collaborations/act-accelerator.html>. Topics include:


Date
Audience
Topic
9 Mar
National/subnational
Regulatory and procurement
16 Mar
Health workers

Understanding COVID-19 vaccines - safety and efficacy
23 Mar
National/subnational

Generating acceptance & demand for COVID-19 vaccines
30 Mar
Health workers
Reporting on COVID-19 vaccines (monitoring and AEFI)
6 April
National/subnational
Vaccination strategies for COVID-19 vaccination



FRANÇAIS

Nous vous avons inclus dans notre liste de diffusion car vous avez un rôle clé dans le déploiement de la vaccination contre la COVID-19. Vous pouvez vous désabonner de cette liste en cliquant sur le lien au bas de ce message.

Chère/cher collègue,

Nous voulons partager des nouvelles ressources disponibles pour soutenir l'introduction des vaccins contre la COVID-19. Pour ces ressources et plus, veuillez visiter la boîte à outils pour l'introduction des vaccins contre la COVID-19<https://www.who.int/tools/covid-19-vaccine-introduction-toolkit/>, qui fournit des conseils, des outils et des formations pour équiper tous les pays à se préparer et mettre en œuvre la vaccination contre la Covid-19. Pour toute question ou commentaire, veuillez envoyer un e-mail à : COVID19vaccineresources@...<mailto:COVID19vaccineresources@...>.


* Les Directives sur la surveillance de la vaccination contre la COVID-19 fournissent des considérations sur : les données minimales et facultatives à collecter au fur et à mesure que les vaccins sont en cours de déploiement et de distribution; des indicateurs de performance clés et leur utilisation prévue—pour mesurer la performance des éléments clés du système de vaccination et prendre des mesures correctives si nécessaire; et l'utilisation de systèmes d'information pour recueillir, stocker, analyser et diffuser toute information pertinente. AN<https://apps.who.int/iris/bitstream/handle/10665/339993/WHO-2019-nCoV-vaccination-monitoring-2021.1-eng.pdf>


* Les données de la vaccination contre la COVID-19 sont désormais disponibles sur le Tableau de bord de l'OMS sur la COVID-19 : covid19.who.int<https://covid19.who.int/>. Ces données sont visualisées en sélectionnant « Vaccination » dans le panneau déroulant sur le côté gauche de la carte. Pour l’instant, le tableau de bord comprend des informations utiles pour suivre le déploiement mondial des vaccins, y compris les doses totales de vaccination administrées, les personnes vaccinées avec au moins une dose et la date de début des vaccinations, par pays, territoire et zone. D'autres fonctionnalités (par exemple des détails sur les produits vaccinaux autorisés et administrés, et les téléchargements de données) seront ajoutées dans un proche avenir.


* Le cours Ressources spécifiques au vaccin contre la COVID-19<https://openwho.org/courses/COVID-19-vaccines> a été lancé sur OpenWHO! D'autres vidéos et ressources concernant d'autres vaccins approuvés pour l’utilisation d'urgence (EUL) ou par présélection seront ajoutées prochainement. Ce mini-cours inclut de courtes vidéos pédagogiques et des explications sur les vaccins sur la manipulation, la préparation et l'administration des vaccins COVID-19 tels que:


· AstraZeneca : cette publication sur le vaccin AstraZeneca ChAdOx1-S / nCoV-19 [recombinant] comprend des informations clés sur les exigences spécifiques du vaccin. AN<https://www.who.int/publications/m/item/chadox1-s-recombinant-covid-19-vaccine> CH<https://www.who.int/docs/default-source/coronaviruse/act-accelerator/covax/21089_chiniese_astrazeneca_vaccine-explainer.pdf?sfvrsn=622e9c36_5> FR<https://www.who.int/docs/default-source/coronaviruse/act-accelerator/covax/21098_french_astrazeneca_vaccine-explainer.pdf?sfvrsn=bf1f7d78_7> PT<https://www.who.int/docs/default-source/coronaviruse/act-accelerator/covax/21105_portuguese_astrazeneca_vaccine-explainer.pdf?sfvrsn=70445997_5> ES<https://www.who.int/docs/default-source/coronaviruse/act-accelerator/covax/21099_spanish_astrazeneca_vaccine-explainer.pdf?sfvrsn=f7250720_5>


· Moderna : cette publication sur le vaccin Moderna COVID-19 comprend des informations clés sur les exigences spécifiques du vaccin. AN<https://www.who.int/publications/m/item/moderna-covid-19-vaccine-(mrna-1273)> CH<https://www.who.int/docs/default-source/coronaviruse/act-accelerator/covax/21081_chinese_moderna-vaccine-explainer.pdf?sfvrsn=7cee8939_5> FR<https://cdn.who.int/media/docs/default-source/immunization/covid-19/21074_french_moderna-vaccine-explainer_24-02-21.pdf?sfvrsn=398f7455_5> PT<https://www.who.int/docs/default-source/coronaviruse/act-accelerator/covax/21103_port_moderna-vaccine-explainer.pdf?sfvrsn=a30e4f_5>


· Pfizer / BioNTech : cette publication sur le vaccin Pfizer Comirnaty Tozinameran comprend des informations clés sur les exigences spécifiques du vaccin. AN<https://www.who.int/publications/m/item/comirnaty-covid-19-mrna-vaccine> AR<https://cdn-auth-cms.who.int/media/docs/default-source/immunization/covid-19/21057_arabic_pfizer-vaccine-explainer_comirnaty_ar.pdf-65-.pdf?sfvrsn=16e275fb_8> CH<https://cdn-auth-cms.who.int/media/docs/default-source/immunization/covid-19/21040_chinese_vaccine-explainer_comirnaty-2.pdf?sfvrsn=271a9940_8> FR<https://cdn-auth-cms.who.int/media/docs/default-source/immunization/covid-19/21067_french_pfizer-vaccine-explainer_comirnaty.pdf?sfvrsn=4bda2d20_8> PT<https://cdn-auth-cms.who.int/media/docs/default-source/immunization/covid-19/21073_portuguese_pfizer-vaccine-explainer_comirnaty_24-02-21.pdf?sfvrsn=17e16e2b_3> RU<https://cdn-auth-cms.who.int/media/docs/default-source/immunization/covid-19/21053_russian_vaccine-explainer_comirnaty.pdf?sfvrsn=b003116d_8> ES<https://cdn.who.int/media/docs/default-source/immunization/covid-19/21066_spanish_pfizer-vaccine-explainer_comirnaty.pdf?sfvrsn=b2224120_10>


* Plus d'informations sont désormais disponibles sur le programme COVAX No-Fault Compensation (NFC) pour les économies éligibles à l’AMC. Le programme sera opérationnel d'ici le 31 mars 2021, avec un portail Web disponible sur www.covaxclaims.com<http://www.covaxclaims.com>. De plus amples informations sur le programme sont disponibles dans cette présentation, qui donne un aperçu du programme. AN<https://www.who.int/publications/m/item/covax-no-fault-compensation-program-for-amc-eligible-economies>


* L’aide de travail Liste de contrôle du vaccin COVID-19 peut aider les agents de santé à se préparer et à terminer une séance de vaccination contre le COVID-19 à un poste fixe ou à une séance de sensibilisation. AN<https://www.who.int/publications/m/item/covid-19-vaccine-checklist>


* Les webinaires sur la vaccination contre la COVID-19 : Renforcement des capacités mondiales organisés par l'OMS et ses partenaires se poursuivent tous les mardis de 12h00 à 13h00 CET (interprétation en français et en espagnol). Vous pouvez regarder les enregistrements des webinaires précédents et vous inscrire aux sessions à venir ici<https://hsc.unm.edu/echo/institute-programs/covid-19-response/international-covid19/who-collaborations/act-accelerator.html>. Les sujets incluent :

Date
Audience
Sujet
9 mars
National / sous-national
Réglementation et acquisition des vaccins
16 mars
Agents de santé
Comprendre les vaccins contre la COVID-19 - sécurité et efficacité
23 mars
National / sous-national
Générer l'acceptation et la demande des vaccins contre la COVID-19
30 mars
Agents de santé
Rapports sur les vaccins contre la COVID-19 (surveillance et ​Manifestions post-vaccinales indésirables - MAPI)
6 avril
National / sous-national
Stratégies nationales de vaccination pour la vaccination contre la COVID-19
13 avril
Agents de santé
Approvisionnement et logistique (à confirmer)
20 avril
National / sous-national
Mobilisation des ressources financières pour l'intensification de la vaccination contre la COVID-19

Cordialement,

Etienne Franca
Consultant
Communications, Advocacy, and Training Working Group
Country Readiness and Delivery for COVID-19 Vaccine introduction
WHO/WHE/IHM/IPR - HQ
Mobile: +351 910 775 772 | +1 203 768 3104
Web: www.who.int<https://www.who.int> – CRD webpage<https://www.who.int/initiatives/act-accelerator/covax/covid-19-vaccine-country-readiness-and-delivery>
Follow WHO on Facebook<https://www.facebook.com/WHO/> | Twitter<https://twitter.com/WHO> | YouTube<https://www.youtube.com/user/who> | Instagram<https://www.instagram.com/who/>

[signature_1373049514]

[signature_1520047599]


________________________________

To unsubscribe from the CRDPARTNERS list, click the following link:
http://listserv.who.int/scripts/wa.exe?TICKET=NzM3ODg4IHRoYXR0ZW5AV0hPLklOVCBDUkRQQVJUTkVSU4bsc%2Btu4ks0&c=SIGNOFF


FW: WHO Living Guideline: Drugs to prevent COVID-19

Nandita Thatte
 

FYI....

Dear Colleagues,

This is to let you know that the “WHO Living Guideline: Drugs to prevent COVID-19” has been published.

It is available in three forms:

WHO website: https://www.who.int/publications/i/item/WHO-2019-nCoV-prophylaxes-2021-1

BMJ publication: https://www.bmj.com/content/372/bmj.n526

MAGICapp: https://app.magicapp.org/#/guidelines

It is also available on the WHO apps:
‎WHO Academy: Covid-19 Learning on the App Store (apple.com)<https://apps.apple.com/us/app/who-academy/id1506019873?ls=1>;
World Health Organization (WHO) Academy – Apps on Google Play<https://play.google.com/store/apps/details?id=org.who.WHOA>

Please do share among your networks and clinical colleagues.

Regards

Wilson

Dr Wilson Milton Were
Medical Officer, Child Health Services
Department of Maternal, Newborn, Child and Adoelscent Health and Ageing (MCA)
Geneva, Switerland
Email: werew@...<mailto:werew@...>
Office: +41 22 791 2661
Mobile: +41 79 217 3459
Skype: wilsonwere
Web: www.who.int<https://www.who.int/>
Follow WHO on Facebook<https://www.facebook.com/WHO/> | Twitter<https://twitter.com/WHO> | YouTube<https://www.youtube.com/user/who> | Instagram<https://www.instagram.com/who/>

[cid:image005.jpg@...]

[Graphical user interface, application Description automatically generated]


Webinar March 3rd--Equitable Access to Covid-19 Vaccine--MENA Region

Nandita Thatte
 

Dear Covid-19 Task Team Members

Please see the event below on equitable access to the Covid-19 Vaccine. Our colleagues from the MENA region will be presenting.

________________________________

Webinar: "Equitable Access to Covid-19 Vaccine". Join us this Wednesday (March 3rd)!
This webinar brings together experts who will discuss the perils of vaccine nationalism. They will investigate what the international community needs to do to improve vaccination coverage for migrants and forcibly displaced people, and what is required to bring an equitable vaccine allocation process in refugee-hosting countries.

Register here: https://lnkd.in/dncK-_6


#vaccineequity<https://www.linkedin.com/feed/hashtag/?keywords=vaccineequity&highlightedUpdateUrns=urn%3Ali%3Aactivity%3A6771382678177497088> #vaccinenationalism<https://www.linkedin.com/feed/hashtag/?keywords=vaccinenationalism&highlightedUpdateUrns=urn%3Ali%3Aactivity%3A6771382678177497088> #covid19vaccine<https://www.linkedin.com/feed/hashtag/?keywords=covid19vaccine&highlightedUpdateUrns=urn%3Ali%3Aactivity%3A6771382678177497088> #covid19vaccination<https://www.linkedin.com/feed/hashtag/?keywords=covid19vaccination&highlightedUpdateUrns=urn%3Ali%3Aactivity%3A6771382678177497088> Columbia Global Centers<https://www.linkedin.com/company/columbiaglobalcenter/>
[a group of people posing for a photo]


FW: COVID-19 Vaccine Introduction Toolbox

Nandita Thatte
 

Dear IBP Colleagues,

Please see the resources below regarding the Launch of the Covid-19 Vaccine Introduction Toolbox. This toolbox provides guidance, tools and training to equip countries to prepare for and implement COVID-19 vaccination. It is being supported as part of the COVAX, the vaccine pillar of the Access to Covid-19 Tools Accelerator. WHO, UNICEF, the GAVI Secretariat and partners are working together at the global and regional levels to develop and disseminate adaptable global resources to support COVID-19 vaccines introduction.

The team is also organizing a series of webinars to further support this work. Webinars will be offered in English, with interpretation into French and Spanish.

Please find additional information including contact details and links to register for the webinars below.

[signature_1483690052]

________________________________

We are thrilled to announce the launch of the COVID-19 vaccine introduction toolbox<https://www.who.int/tools/covid-19-vaccine-introduction-toolkit/>, which provides guidance, tools and training to equip countries to prepare for and implement COVID-19 vaccination. This toolbox—intended to support Ministries of Health, health workers, partner organizations, and other stakeholders—is organized in line with the Guidance on Developing a National Deployment and Vaccination Plan for COVID-19 vaccines<https://www.who.int/publications/i/item/WHO-2019-nCoV-Vaccine_deployment-2020.1> and will be updated as new resources become available.

We would also like to inform you about the COVID-19 Vaccination: Building Global Capacity webinar sessions<https://hsc.unm.edu/echo/institute-programs/covid-19-response/international-covid19/who-collaborations/act-accelerator.html>, which may be of interest. These one-hour sessions are held on Tuesdays from 12:00 -13:00 CET. Interpretation into French and Spanish is available. More information is available in the attached presentation. Additional sessions will be announced shortly.

Sessions:


* 23 Feb: Indemnification and Liability for national and sub-national focal points. Watch the recording in EN<https://youtu.be/0u3FNl0GbZs> SP<https://youtu.be/lvm6WiC_2go> FR<https://youtu.be/nJ4hW6SIJrc>
* 2 Mar: Infection Prevention and Control for health workers. Register here<https://echo.zoom.us/webinar/register/WN_81Wgk82kRcmmMVJ43SNOuA>
* 9 Mar: Regulatory and Procurement for national and sub-national focal points. Register here<https://echo.zoom.us/webinar/register/WN_60QBnRtURmaoXz2mGFWPIQ>

We would appreciate if you could share this information and resources as broadly as possible!

It would be great if you could pass along this message to the communities of practice you have access to and its members as appropriate, who can subscribe to our list by sending a message to me at francae@...<mailto:francae@...>. For questions, comments or feedback about the resources please e-mail: COVID19vaccineresources@...<mailto:COVID19vaccineresources@...>.

I hope we can include you on our listserv as you have a key role in COVID-19 vaccination rollout. Please let me know if that would be acceptable.

Best regards,

Etienne Franca


Etienne Franca
Consultant
Communications, Advocacy, and Training Working Group
Country Readiness and Delivery for COVID-19 Vaccine introduction
WHO/WHE/IHM/IPR - HQ
Mobile: +351 910 775 772 | +1 203 768 3104
Web: www.who.int<https://www.who.int> – CRD webpage<https://www.who.int/initiatives/act-accelerator/covax/covid-19-vaccine-country-readiness-and-delivery>
Follow WHO on Facebook<https://www.facebook.com/WHO/> | Twitter<https://twitter.com/WHO> | YouTube<https://www.youtube.com/user/who> | Instagram<https://www.instagram.com/who/>

[signature_526381095]


[signature_1483690052]


Webinar Recording: COVID-19 and Digital

Natalie Apcar
 

Dear colleagues of the COVID-19 & FP/RH Task Team,

 

Thank you to those of us who were able to join the webinar yesterday, February 17th 2021, titled: COVID-19 and Digital: How a different kind of virus has accelerated the uptake of digital platforms in FP/RH. We would also like to extend thanks to our thoughtful presenters and moderators who created a very informative and rich webinar.

 

Please find the links to the English and French recordings via the Resources page here.

 

Sincerely,

Natalie, Nandita, and Trinity, task team co-chairs

 

 

 


IBP COVID-19 and FP/RH Program Adaptations Interactive Map/Carte interactive de l'IBP des adaptations des programmes PF/SR pour le COVID-19

Trinity Zan
 

Dear IBP Colleagues,

 

In mid-2020, the IBP COVID-19 and FP/RH Task Team created a shared online spreadsheet in order to capture information about how FP/RH programs were adapting to challenges presented by COVID-19. Many of you have entered information, making this a rich repository. Based on your feedback, we are building an interactive map to visualize this information. If you have contributed to the spreadsheet, we will be reaching out to obtain your consent and to follow-up with next steps. Please look for an e-mail from Ameya Sanyal (asanyal@...) or Sarah Brittingham (sbrittingham@...). If you have not contributed to the spreadsheet and would like to, please follow this link and enter information in all columns (including the highlighted ones). Thank you for your continued collaboration and we look forward to sharing the interactive map with you in the new year!

 

Sincerely,

 

Trinity, Nandita and Natalie (IBP COVID-19 and FP/RH Task Team Co-Chairs)

 

 

Chers collègues de l'IBP,

 

Mi-2020, l'équipe de travail de l'IBP pour le COVID-19 et PF/SR a partagé une feuille de calcul en ligne afin de saisir des informations sur la manière dont les programmes PF/SR s'adaptaient aux défis présentés par COVID-19. Nombre d'entre vous y ont inscrit des informations, ce qui a fait un riche répertoire. Sur la base de vos commentaires, nous sommes en train de construire une carte interactive pour visualiser ces informations. Si vous avez contribué à la feuille de calcul, nous vous contacterons pour obtenir votre consentement et pour assurer le suivi des prochaines étapes. Vous recevrez un e-mail d'Ameya Sanyal (asanyal@...) ou de Sarah Brittingham (sbrittingham@...). Si vous n'avez pas contribué à la feuille de calcul et vous souhaitez le faire, Si vous n'avez pas contribué à la feuille de calcul et vous souhaitez le faire, veuillez suivre ce lien et insérez les informations dans toutes les colonnes (y compris celles soulignes). Nous vous remercions de votre collaboration continue et nous serons contentes de partager la carte interactive avec vous au cours de la nouvelle année !

 

Cordialement,

 

Trinity, Nandita et Natalie (co-présidentes de l'équipe de travail de l'IBP pour le COVID-19 et PF/SR)

 

 

Trinity Zan |Associate Director, Research Utilization, GHPN

359 Blackwell Street, Suite 200| Durham, NC  27701

919-544-7040 x11404|  tzan@... | www.fhi360.orgFHI 360 Facebook
 skype: trinityzan

 

 


Les grossesses précoces et non désirées durant la COVID-19 : quelles sont les stratégies efficaces de lutte?

Katelyn Bryant-Comstock
 

Ce webinaire peut présenter un intérêt pour ce groupe:

Vous êtes invité à un webinaire Zoom qu’organisent les Jeunes Ambassadeurs SR/PF.
Quand: 4 déc. 2020 02:30 PM Temps universel coordonné
Sujet: Les grossesses précoces et non désirées durant la COVID-19 : quelles sont les stratégies efficaces de lutte?

Veuillez vous inscrire à la date et l’heure qui vous conviennent le mieux :
https://us02web.zoom.us/webinar/register/WN_LZ_6M9PXR2uc9huBGJt8pQ


IBP Covid-19 Task Team Webinar Series: Regional Experiences from Asia--Thursday 10 December 7amEST/18:30Myanmar/20hMalaysia/Philippines

Nandita Thatte
 

Dear IBP Colleagues

As a follow up to the Covid-19 Webinars we held in April 2020, the IBP Covid-19 Task Team will be hosting follow up Regional Webinars to re-visit and learn about challenges and successes in maintaining family planning and reproductive health services during the Covid-19 pandemic. The first in our series will feature regional and country experiences from Asia.

Please register below and join us on Thursday December 10th at 7amEST/13hCEST/18:30hMyanmar/20hPhilippines

Register Here: https://who.zoom.us/webinar/register/WN_3RF7dTQ0Q9C_a2yZIfpnsg

To join the IBP Covid-19 Task Team, visit: www.ibpnetwork.org<http://www.ibpnetwork.org> --> IBPXchange --> Covid-19 Task Team

[cid:image004.jpg@...]<https://who.zoom.us/webinar/register/WN_3RF7dTQ0Q9C_a2yZIfpnsg>



Nandita Thatte, DrPH
Department of Sexual and Reproductive Health
World Health Organization
Geneva, Switzerland
Email: thatten@...<mailto:thatten@...>
www.ibpnetwork.org<http://www.who.int/reproductivehealth>

[cid:image001.png@...]


Updated agenda: Covid-19 Task Team Monthly Meeting | Ordre du jour mis à jour: Réunion mensuelle de l'équipe de travail Covid-19

anne.ballard@...
 

*See below for English


Chers membres de l'équipe de travail COVID-19, 

 

Veuillez réserver la date de notre prochaine réunion de la Task Team pour le mercredi 18 novembre à 9h EST. La réunion se déroulera en français avec traduction simultanée en anglais.


Au cours de cette réunion, Dr Maréme Mady Dia Ndiaye avec le Départment de Santé Mére et Enfant au Senegal et Aissatou Thioye du projet Knowledge SUCCESS de FHI 360 discutera de l'expérience du Sénégal en matière d'accès à la PF/SR lors de la COVID-19. 

  • Dr Marème Mady Dia Ndiaye est cheffe de la division planification familiale à la direction de la Santé de la Mère et de l’Enfant (DSME). Elle capitalise plus de 20 ans d’expérience dans le système de santé au Sénégal où elle a eu à occuper des postes depuis le niveau opérationnel au niveau central. Sa passion pour la planification familiale s’est affirmée en 2010 en tant que Médecin chef du District de Pikine où elle a contribué à la mise en œuvre du Projet ISSU (Initiative Sénégalaise de Santé Urbaine) avant de rejoindre en 2013 le niveau central au sein de la DSME en tant que Conseillère Technique dans le cadre du projet de Renforcement des Prestations de Services de Intrahealth. Marème est spécialiste en Santé Publique, épidémiologie et bio statistiques.
  • Aissatou Thioye est la responsable de la gestion des connaissances et des partenariats du projet Knowledge SUCCESS pour l'Afrique de l'Ouest. Aissatou a plus de 15 ans d'expérience dans le domaine de la communication. Elle a commencé sa carrière dans la communication en tant que journaliste de la presse écrite et a travaillé sur des documentaires télévisés axés sur les questions sociales et de développement. Puis, en 2015, elle est passée à la santé publique où elle a travaillé en tant que spécialiste des médias de masse et en tant que responsable de la gestion des connaissances aux niveaux régional et national.

Veuillez transmettre cette invitation à toute personne susceptible d'être intéressée à participer. Vous trouverez les détails de l'appel ci-dessous. Nous sommes impatients de vous rencontrer ! 

 

Nous vous remercions,

Les coprésidents de l'équipe de travail


---


Dear COVID-19 Task Team Members, 

 

Please save the date for our next Task Team meeting Wednesday, November 18th at 9am EST.  The meeting will be conducted in French with simultaneous translation to English.

 

During this meeting Dr. Marème Mady Dia Ndiaye from the Senegal Mother and Child Health Department and Aissatou Thioye from the Knowledge SUCCESS project at FHI 360 will be discussing Senegal’s experience regarding access to FP/RH during COVID-19.

  • Dr. Marème Mady Dia Ndiaye is head of the family planning division at the Directorate of Mother and Child Health (DSME). She capitalizes on more than 20 years of experience in the health system in Senegal where she has occupied positions from the operational level to the central level. Her passion for family planning was affirmed in 2010 as Chief Physician of the District of Pikine where she contributed to the implementation of the ISSU Project (Senegalese Urban Health Initiative) before joining the central level within of DSME as Technical Advisor for the Intrahealth Service Delivery Strengthening project in 2013. Marème is a specialist in Public Health, epidemiology, and bio statistics.
  • Aissatou Thioye is the Knowledge SUCCESS project’s West Africa Knowledge Management and Partnerships Officer. Aissatou has over 15 years of communications experience. She started her career in communications as a print journalist and working on TV documentaries that focused on social and development issues. Then in 2015, she transitioned to public health where she has worked as a mass media specialist and as regional and national knowledge management focal person.

Please forward this invite to anyone who may be interested in attending. You can find the Zoom details for the call below. We look forward to connecting with you! 

 

Thank you,

The Task Team Co-Chairs 


--


Join Zoom Meeting

https://us02web.zoom.us/j/82240914351


Meeting ID: 822 4091 4351

One tap mobile

+13017158592,,82240914351# US (Germantown)

+16465588656,,82240914351# US (New York)


Dial by your location

        +1 301 715 8592 US (Germantown)

        +1 646 558 8656 US (New York)

        +1 312 626 6799 US (Chicago)

        +1 253 215 8782 US (Tacoma)

        +1 346 248 7799 US (Houston)

        +1 669 900 9128 US (San Jose)

Meeting ID: 822 4091 4351

Find your local number: https://us02web.zoom.us/u/kcg2B3uDDo



Covid-19 Task Team Monthly Meeting

anne.ballard@...
 

*See below for English


Chers membres de l'équipe de travail COVID-19, 

 

Veuillez réserver la date de notre prochaine réunion de la Task Team pour le mercredi 18 novembre à 9h EST. La réunion se déroulera en français avec traduction simultanée en anglais.


Au cours de cette réunion, Aissatou Thioye du projet Knowledge SUCCESS de FHI 360 discutera de l'expérience du Sénégal en matière d'accès à la PF/SR lors de la COVID-19. 

  • Aissatou Thioye est la responsable de la gestion des connaissances et des partenariats du projet Knowledge SUCCESS pour l'Afrique de l'Ouest. Aissatou a plus de 15 ans d'expérience dans le domaine de la communication. Elle a commencé sa carrière dans la communication en tant que journaliste de la presse écrite et a travaillé sur des documentaires télévisés axés sur les questions sociales et de développement. Puis, en 2015, elle est passée à la santé publique où elle a travaillé en tant que spécialiste des médias de masse et en tant que responsable de la gestion des connaissances aux niveaux régional et national.

Veuillez transmettre cette invitation à toute personne susceptible d'être intéressée à participer. Vous trouverez les détails de l'appel ci-dessous. Nous sommes impatients de vous rencontrer ! 

 

Nous vous remercions,

Les coprésidents de l'équipe de travail


---


Dear COVID-19 Task Team Members, 

 

Please save the date for our next Task Team meeting Wednesday, November 18th at 9am EST.  The meeting will be conducted in French with simultaneous translation to English.

 

During this meeting Aissatou Thioye from the Knowledge SUCCESS project at FHI 360 will be discussing Senegal’s experience regarding access to FP/RH during COVID-19.

  • Aissatou Thioye is the Knowledge SUCCESS project’s West Africa Knowledge Management and Partnerships Officer. Aissatou has over 15 years of communications experience. She started her career in communications as a print journalist and working on TV documentaries that focused on social and development issues. Then in 2015, she transitioned to public health where she has worked as a mass media specialist and as regional and national knowledge management focal person.

Please forward this invite to anyone who may be interested in attending. You can find the Zoom details for the call below. We look forward to connecting with you! 

 

Thank you,

The Task Team Co-Chairs 


--


Join Zoom Meeting

https://us02web.zoom.us/j/82240914351


Meeting ID: 822 4091 4351

One tap mobile

+13017158592,,82240914351# US (Germantown)

+16465588656,,82240914351# US (New York)


Dial by your location

        +1 301 715 8592 US (Germantown)

        +1 646 558 8656 US (New York)

        +1 312 626 6799 US (Chicago)

        +1 253 215 8782 US (Tacoma)

        +1 346 248 7799 US (Houston)

        +1 669 900 9128 US (San Jose)

Meeting ID: 822 4091 4351

Find your local number: https://us02web.zoom.us/u/kcg2B3uDDo


1 - 20 of 52